From: Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
 | ISUP grade groups | p-value | ||
---|---|---|---|---|
1 | 2 and 3 | 4 and 5 | ||
n = 8 | n = 91 | n = 90 | ||
SUVmax of primary tumour (n = 183), median (IQR)a | 8.4 (5.2–15.2) | 14.9 (8.8–24.3) | 19.6 (11.9–32.3) | 0.004 |
Regional nodes (n = 189), %(n/Total)b | 12.5% (1/8) | 11.0% (10/91) | 31.1% (28/90) | 0.003 |
Non-regional nodes (n = 189), %(n/Total)b | 0% (0/8) | 4.4% (4/91) | 14.4% (13/90) | 0.041 |
Bone metastasis (n = 189), %(n/Total) b | 0% (0/8) | 12.1% (11/91) | 28.9% (26/90) | 0.006 |
Visceral metastasis (n = 189), %(n/Total) b | 0% (0/8) | 3.3% (3/91) | 4.4% (4/90) | 0.78 |